In one paragraphArticle in Journal of comparative effectiveness research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors at 12 institutions in 1 country.
Francisco MarínDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, CIBERCV, Murcia, Spain.ORCID 0000-0001-7246-7708 Marcelo Sanmartín FernándezDepartment of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain.ORCID 0000-0001-5469-4579 Gonzalo Barón-EsquiviasDepartment of Cardiology, Hospital Universitario Virgen del Rocio, Universidad de Sevilla, Sevilla, Spain.ORCID 0000-0002-9103-4753 Vivencio BarriosDepartment of Cardiology, University Hospital Ramón y Cajal, Alcalá University, Madrid, Spain.ORCID 0000-0001-6135-7685 Alejandro I Pérez-CabezaDepartment of Cardiology, Virgen de la Victoria University Hospital, Málaga, Spain.ORCID 0000-0002-4799-4263 Jaime MasjuanServicio de Neurología, Hospital Universitario Ramón y Cajal, IRYCIS, Departamento de Medicina, Universidad de Alcalá. Red INVICTUS, Madrid, Spain.ORCID 0000-0003-1329-0943 Esther Recalde Del VigoHospital Universitario de Basurto, Centro Médico San Juan de Dios, Bizkaia, Spain.
José Manuel Vázquez RodríguezDepartment of Cardiology, Complejo Hospitalario Universitario A Coruña, INIBIC, CIBERCV, A Coruña, Spain.ORCID 0000-0003-0888-6937 Vanessa Roldán SchillingDepartment of Haematology & Clinical Oncology, Hospital Universitario Morales Meseguer. University of Murcia, Murcia, Spain.ORCID 0000-0002-4945-6602 Fernando ArribasDepartment of Cardiology, Hospital Universitario 12 de Octubre, Department of Medicine, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain.ORCID 0000-0002-2574-7923 Manuel Anguita SánchezDepartment of Cardiology, Hospital Reina Sofía Córdoba, IMIBIC, University of Cordoba, Córdoba, Spain.ORCID 0000-0001-7875-7263 Universidad de Alcalá · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital de Basurto · ESHospital de Galdakao · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital General Universitario Morales Meseguer · ESHospital Universitario Ramón y Cajal · ESInstituto de Biotecnología de León · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversidad Complutense de Madrid · ES
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Atrial FibrillationCardiovascular DiseasesCoronary Artery DiseasePeripheral Arterial DiseaseStrokeAnticoagulantsFactor Xa InhibitorsHumansProspective StudiesRivaroxabanAnticoagulantsFactor Xa InhibitorsRivaroxabanatrial fibrillationbleedingcoronary artery diseaseEMIRMACEmyocardial infarctionperipheral artery diseaserivaroxabanstrokevascular disease
Identifiers
PMID36749006
PMCPMC10288946
OpenAlexW4319332978
What OpenQuestion holds
Textmetadata
Read underepoch 390